First prospective study of its kind conducted in primary care settings, shows remarkable diagnostic performance: 95% sensitivity and 86% specificity,...
Clinical study in Swedish primary care facilities to validate Dermalyser AI-driven decision support tool for diagnosing malignant melanoma progressing well...
AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing melanoma skin cancer
AI Medical Technology Receives ISO 13485:2016 Certification